0001181431-12-002267.txt : 20120111
0001181431-12-002267.hdr.sgml : 20120111
20120111174104
ACCESSION NUMBER: 0001181431-12-002267
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120110
FILED AS OF DATE: 20120111
DATE AS OF CHANGE: 20120111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KISHBAUCH MICHAEL D
CENTRAL INDEX KEY: 0001076979
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 12522777
MAIL ADDRESS:
STREET 1: 18 CHERRYVILLE RD
CITY: FLEMINGTON
STATE: NJ
ZIP: 08822
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070336
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-624-7000
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4
1
rrd330437.xml
KISHBAUCH 01.10.12 SALE
X0304
4
2012-01-10
0
0001070336
ACHILLION PHARMACEUTICALS INC
ACHN
0001076979
KISHBAUCH MICHAEL D
C/O ACHILLION PHARMACEUTICALS
300 GEORGE STREET
NEW HAVEN
CT
06511
1
1
0
0
CEO and President
Common Stock
2012-01-10
4
M
0
90209
1.60
A
90209
D
Common Stock
2012-01-10
4
S
0
90209
10.0149
D
0
D
Common Stock
2012-01-11
4
M
0
8900
1.60
A
8900
D
Common Stock
2012-01-11
4
S
0
8900
12.5021
D
0
D
Employee Stock Option (Right to Buy)
1.60
2012-01-10
4
M
0
90209
0
D
2014-07-20
Common Stock
90209
90209
D
Employee Stock Option (Right to Buy)
1.60
2012-01-11
4
M
0
8900
0
D
2014-07-20
Common Stock
8900
81309
D
The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $10.00 to $10.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
This option was granted on July 20, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $12.50 to $12.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kishbauch on June 7, 2011.
/s/ Michael Kishbauch
2012-01-11